Search

Search Constraints

You searched for: Author/Creator Halperin, Tami

Search Results

1. BNT162b2 mRNA COVID‐19 vaccine booster induces seroconversion in patients with B‐cell non‐Hodgkin lymphoma who failed to respond to two prior vaccine doses. (25th January 2022)

2. Immunogenicity and Safety of the BNT162b2 mRNA COVID-19 Vaccine Among Actively Treated Cancer Patients. (28th August 2021)

3. Kidney transplant recipients vaccinated before transplantation maintain superior humoral response to SARS‐CoV‐2 vaccine. Issue 12 (29th September 2021)

4. Reduced humoral response to mRNA SARS‐CoV‐2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus. Issue 8 (7th May 2021)

5. Seroprevalence of anti-HBs antibodies at young adulthood, before and after a booster vaccine dose, among medical personnel vaccinated in infancy. Issue 38 (11th September 2015)

6. Seroprevalence of anti-HBs antibodies at young adulthood, before and after a booster vaccine dose, among medical personnel vaccinated in infancy. Issue 38 (11th September 2015)

7. The association of maternal SARS‐CoV‐2 vaccination‐to‐delivery interval and the levels of maternal and cord blood antibodies. Issue 3 (20th November 2021)

8. The effect of a third-dose BNT162b2 vaccine on anti-SARS-CoV-2 antibody levels in immunosuppressed patients. (May 2022)

9. The spectrum of bacteria and mechanisms of resistance identified from the casualties treated in the Israeli field hospital after the earthquake in Nepal, 2015: A retrospective analysis. Issue 37 (September 2020)